MIR34A (MicroRNA 34a-5p)

News alerts, weekly reports and conference planners

Entrez ID:

miR-34a-5p underexpression	Ovarian Cancer	miR-34a-5p underexpression	Ovarian Cancer	nintedanib Sensitive: C3 – Early Trials nintedanib Sensitive : C3	nintedanib Sensitive: C3 – Early Trials nintedanib Sensitive : C3
miR-34a overexpression	Non Small Cell Lung Cancer	miR-34a overexpression	Non Small Cell Lung Cancer	Immunotherapy Sensitive: C3 – Early Trials Immunotherapy Sensitive : C3	Immunotherapy Sensitive: C3 – Early Trials Immunotherapy Sensitive : C3
miR-34a underexpression	Lung Non-Squamous Non-Small Cell Cancer	miR-34a underexpression	Lung Non-Squamous Non-Small Cell Cancer	nivolumab Resistant: C3 – Early Trials nivolumab Resistant : C3	nivolumab Resistant: C3 – Early Trials nivolumab Resistant : C3
miR-34a expression	Triple Negative Breast Cancer	miR-34a expression	Triple Negative Breast Cancer	selinexor Sensitive: D – Preclinical selinexor Sensitive : D	selinexor Sensitive: D – Preclinical selinexor Sensitive : D

Associations(4)